Solventum (SOLV) to Release Quarterly Earnings on Thursday

Solventum (NYSE:SOLV) will likely be issuing its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of $1.31 per share and revenue of $2.05 billion for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Solventum Price Performance

Shares of SOLV opened at $76.30 on Tuesday. The business has a fifty day moving average of $71.28 and a 200 day moving average of $69.37. Solventum has a 52-week low of $47.16 and a 52-week high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on SOLV shares. Morgan Stanley increased their target price on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. Mizuho initiated coverage on Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. Finally, Piper Sandler lifted their target price on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $68.29.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.